메뉴 건너뛰기




Volumn 60, Issue 4, 2009, Pages 163-167

The CYP17 and CYP19 gene single nucleotide polymorphism in women with sporadic breast cancer

Author keywords

Breast cancer; CYP17; CYP19; PCR RFLP; Polymorphism

Indexed keywords

AROMATASE; STEROID 17ALPHA MONOOXYGENASE;

EID: 77951651603     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)

References (32)
  • 1
    • 47349132331 scopus 로고    scopus 로고
    • Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: A positive association with combined CYP/GST genotypes
    • Torresan C, Oliveira MM, Torrezan GT, et al. Genetic polymorphisms in oestrogen metabolic pathway and breast cancer: a positive association with combined CYP/GST genotypes. Clin Exp Med 2008; 8: 65-71.
    • (2008) Clin Exp Med , vol.8 , pp. 65-71
    • Torresan, C.1    Oliveira, M.M.2    Torrezan, G.T.3
  • 2
    • 40449096211 scopus 로고    scopus 로고
    • Association of CYP1A1 polymorphisms with breast cancer in North Indian women
    • Singh N, Mitra AK, Garg VK, et al. Association of CYP1A1 polymorphisms with breast cancer in North Indian women. Oncol Res. 2007; 16: 587-597.
    • (2007) Oncol Res , vol.16 , pp. 587-597
    • Singh, N.1    Mitra, A.K.2    Garg, V.K.3
  • 3
    • 3042826342 scopus 로고    scopus 로고
    • Estrogenmetabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women
    • Hefler LA, Tempfer CB, Grimm C, et al. Estrogenmetabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Cancer. 2004; 101: 264-269.
    • (2004) Cancer , vol.101 , pp. 264-269
    • Hefler, L.A.1    Tempfer, C.B.2    Grimm, C.3
  • 4
    • 2942598063 scopus 로고    scopus 로고
    • Cytochrome P450 gene polymorphism and cancer
    • Agundez JA. Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 2004; 5: 211-224.
    • (2004) Curr Drug Metab , vol.5 , pp. 211-224
    • Agundez, J.A.1
  • 5
    • 18344381189 scopus 로고    scopus 로고
    • CYP17 genetic polymorphism in endometrial cancer: Are only steroids involved?
    • Berstein LM, Imyanitov EN, Gamajunova VB, et al. CYP17 genetic polymorphism in endometrial cancer: are only steroids involved? Cancer Lett 2002; 180: 47-53.
    • (2002) Cancer Lett , vol.180 , pp. 47-53
    • Berstein, L.M.1    Imyanitov, E.N.2    Gamajunova, V.B.3
  • 6
    • 41849119124 scopus 로고    scopus 로고
    • Estrogenbiosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: Results from the Long Island. Breast Cancer Study Project
    • Chen Y, Gammon MD, Teitelbaum SL, et al. Estrogenbiosynthesis gene CYP17 and its interactions with reproductive, hormonal and lifestyle factors in breast cancer risk: results from the Long Island. Breast Cancer Study Project. Carcinogenesis 2008; 29: 766-771.
    • (2008) Carcinogenesis , vol.29 , pp. 766-771
    • Chen, Y.1    Gammon, M.D.2    Teitelbaum, S.L.3
  • 7
    • 33846616798 scopus 로고    scopus 로고
    • CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients
    • Chakraborty A, Murthy NS, Chintamani C, et al. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients. J Hum Genet 2007; 52: 159-165.
    • (2007) J Hum Genet , vol.52 , pp. 159-165
    • Chakraborty, A.1    Murthy, N.S.2    Chintamani, C.3
  • 8
    • 3042536361 scopus 로고    scopus 로고
    • Genetic polymorphism of steroidogenic enzymes and steroid receptor level in tumors of the reproductive system
    • Berstein LM, Zimarina TS, Tsyrlina EV, et al. Genetic polymorphism of steroidogenic enzymes and steroid receptor level in tumors of the reproductive system. Vopr Onkol 2004; 50: 169-173.
    • (2004) Vopr Onkol , vol.50 , pp. 169-173
    • Berstein, L.M.1    Zimarina, T.S.2    Tsyrlina, E.V.3
  • 9
    • 0034691559 scopus 로고    scopus 로고
    • Breast cancer risk associated with polymorphism in CYP19 in Japanese women
    • Miyoshi Y, Iwao K, Ikeda N, et al. Breast cancer risk associated with polymorphism in CYP19 in Japanese women. Int J Cancer 2000; 89: 325-8
    • (2000) Int J Cancer , vol.89 , pp. 325-328
    • Miyoshi, Y.1    Iwao, K.2    Ikeda, N.3
  • 10
    • 0032518994 scopus 로고    scopus 로고
    • Cytochrome P450c17a gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations
    • Feigelson HS, Shames LS, Pike MC, et al. Cytochrome P450c17a gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res 1998; 58: 585-587.
    • (1998) Cancer Res , vol.58 , pp. 585-587
    • Feigelson, H.S.1    Shames, L.S.2    Pike, M.C.3
  • 11
    • 0032475436 scopus 로고    scopus 로고
    • Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women
    • Hankinson SE, Wilett WC, Manson JE, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998; 90: 1292-1299.
    • (1998) J Natl Cancer Inst , vol.90 , pp. 1292-1299
    • Hankinson, S.E.1    Wilett, W.C.2    Manson, J.E.3
  • 12
    • 0030888153 scopus 로고    scopus 로고
    • A polymorphism in the CYP17 gene increases the risk of breast cancer
    • Feigelson HS, Coetzee GA, Kolonel LN, et al. A polymorphism in the CYP17 gene increases the risk of breast cancer. Cancer Res 1997; 57: 1063-1065.
    • (1997) Cancer Res , vol.57 , pp. 1063-1065
    • Feigelson, H.S.1    Coetzee, G.A.2    Kolonel, L.N.3
  • 13
    • 0033771003 scopus 로고    scopus 로고
    • Role of aromatase in sex steroid action
    • Simpson ER. Role of aromatase in sex steroid action. J Mol Endocrinol 2000; 25: 149-156.
    • (2000) J Mol Endocrinol , vol.25 , pp. 149-156
    • Simpson, E.R.1
  • 14
    • 0032961719 scopus 로고    scopus 로고
    • Constitutional genetic variation at the human aromatase gene (CYP19) and breast cancer risk
    • Siegelmann-Danieli N, Buetow KH. Constitutional genetic variation at the human aromatase gene (CYP19) and breast cancer risk. Br. J. Cancer 1999; 79: 456-463.
    • (1999) Br. J. Cancer , vol.79 , pp. 456-463
    • Siegelmann-Danieli, N.1    Buetow, K.H.2
  • 15
    • 0034744673 scopus 로고    scopus 로고
    • A common promoter variant in the cytochrome P450c17 (CYP17) gene is associated with bioavailable testosterone levels and bone size in men
    • Zmuda J.M, Cauley JA, Kuller LH, et al. A common promoter variant in the cytochrome P450c17 (CYP17) gene is associated with bioavailable testosterone levels and bone size in men. J Bone Miner Res 2001; 16: 911-917.
    • (2001) J Bone Miner Res , vol.16 , pp. 911-917
    • Zmuda, J.M.1    Cauley, J.A.2    Kuller, L.H.3
  • 16
    • 0029612331 scopus 로고
    • Hormones and cancer in humans
    • Key TJ. Hormones and cancer in humans. Mutat Res 1995; 333: 59-67.
    • (1995) Mutat Res , vol.333 , pp. 59-67
    • Key, T.J.1
  • 17
    • 0032518994 scopus 로고    scopus 로고
    • Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations
    • Feigelson HS, Shames LS, Pike MC, et al. Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations. Cancer Res 1998; 58: 585-587.
    • (1998) Cancer Res , vol.58 , pp. 585-587
    • Feigelson, H.S.1    Shames, L.S.2    Pike, M.C.3
  • 18
    • 0033104346 scopus 로고    scopus 로고
    • The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer
    • Haiman CA, Hankinson SE, Spiegelman D, et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 1999; 59: 1015-1020.
    • (1999) Cancer Res , vol.59 , pp. 1015-1020
    • Haiman, C.A.1    Hankinson, S.E.2    Spiegelman, D.3
  • 19
    • 0035014268 scopus 로고    scopus 로고
    • Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5'UTR in patients with polycystic ovarian syndrome
    • Marszałek B, Laciński M, Babych N, et al. Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5'UTR in patients with polycystic ovarian syndrome. Gynecol. Endocrinol. 2001; 15: 123-128.
    • (2001) Gynecol. Endocrinol , vol.15 , pp. 123-128
    • Marszałek, B.1    Laciński, M.2    Babych, N.3
  • 20
    • 0033564094 scopus 로고    scopus 로고
    • CYP17 and breast cancer risk: The polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1
    • Nedelcheva V, Haraldsen EK, Anderson KB, et al. CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1. Cancer Res 1999; 59: 2825-2828.
    • (1999) Cancer Res , vol.59 , pp. 2825-2828
    • Nedelcheva, V.1    Haraldsen, E.K.2    Anderson, K.B.3
  • 21
    • 0033104346 scopus 로고    scopus 로고
    • The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer
    • Haiman CA, Hankinson SE, Spiegelman D, et al. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer. Cancer Res 1999; 59: 1015-1020.
    • (1999) Cancer Res , vol.59 , pp. 1015-1020
    • Haiman, C.A.1    Hankinson, S.E.2    Spiegelman, D.3
  • 22
    • 2942683102 scopus 로고    scopus 로고
    • Polymorphisms associated with circulating sex hormone levels in postmenopausal women
    • Dunning AM, Dowsett M, Healey CS, et al. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. J Natl Cancer Inst 2004; 96: 936-945.
    • (2004) J Natl Cancer Inst , vol.96 , pp. 936-945
    • Dunning, A.M.1    Dowsett, M.2    Healey, C.S.3
  • 23
    • 0038059295 scopus 로고    scopus 로고
    • Association of CYP17 genetic polymorphism with intra-tumoral estradiol concentrations but not with CYP17 messenger RNA levels in breast cancer tissue
    • Miyoshi Y, Ando A, Ooka M, et al. Association of CYP17 genetic polymorphism with intra-tumoral estradiol concentrations but not with CYP17 messenger RNA levels in breast cancer tissue. Cancer Lett 2003; 195: 81-86.
    • (2003) Cancer Lett , vol.195 , pp. 81-86
    • Miyoshi, Y.1    Ando, A.2    Ooka, M.3
  • 24
    • 0035804638 scopus 로고    scopus 로고
    • CYP17 promoter polymorphism and breast cancer in Australian women under age forty years
    • Jernstrom H, Vesprini D, Bradlow HL, et al. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. J Natl Cancer Inst 2001; 93: 554-555.
    • (2001) J Natl Cancer Inst , vol.93 , pp. 554-555
    • Jernstrom, H.1    Vesprini, D.2    Bradlow, H.L.3
  • 25
    • 12344312120 scopus 로고    scopus 로고
    • Association between the T27C polymorphism in the cytochrome P450 c17alpha (CYP17) gene and risk factors for breast cancer
    • Hong C, Thompson H, Jiang C, et al. Association between the T27C polymorphism in the cytochrome P450 c17alpha (CYP17) gene and risk factors for breast cancer. Breast Cancer Res Treat 2004; 88: 217-230.
    • (2004) Breast Cancer Res Treat , vol.88 , pp. 217-230
    • Hong, C.1    Thompson, H.2    Jiang, C.3
  • 26
    • 0032773048 scopus 로고    scopus 로고
    • Association between CYP17 gene polymorphism and risk of breast cancer in young women
    • Bergman-Jungestrom M, Gentile M, Lundin AC, et al. Association between CYP17 gene polymorphism and risk of breast cancer in young women. Int. J. Cancer 1999; 84: 350-353.
    • (1999) Int. J. Cancer , vol.84 , pp. 350-353
    • Bergman-Jungestrom, M.1    Gentile, M.2    Lundin, A.C.3
  • 27
    • 0034523157 scopus 로고    scopus 로고
    • Steroid metabolism gene CYP17 polymorphism and the development of breast cancer
    • Mitrunen K, Jourenkova N, Kataja V, et al. Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. Cancer Epidemiol. Biomarkers Prev. 2000; 9: 1343-1348.
    • (2000) Cancer Epidemiol. Biomarkers Prev , vol.9 , pp. 1343-1348
    • Mitrunen, K.1    Jourenkova, N.2    Kataja, V.3
  • 28
    • 0034684119 scopus 로고    scopus 로고
    • CYP17 promoter polymorphism and breast cancer in Australian women under age forty years
    • Spurdle AB, Hopper JL, Dite GS, et al. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. J. Natl. Cancer Inst 2000; 92: 1674-1681.
    • (2000) J. Natl. Cancer Inst , vol.92 , pp. 1674-1681
    • Spurdle, A.B.1    Hopper, J.L.2    Dite, G.S.3
  • 29
    • 0036121362 scopus 로고    scopus 로고
    • The CYP17 MspA1 polymorphism and breast cancer risk: A meta-analysis
    • Ye Z, Parry JM. The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis. Mutagenesis 2002; 17: 119-126.
    • (2002) Mutagenesis , vol.17 , pp. 119-126
    • Ye, Z.1    Parry, J.M.2
  • 30
    • 0035112692 scopus 로고    scopus 로고
    • Polymorphic variation in CYP19 and the risk of breast cancer
    • Baxter SW, Choong DY, Eccles DM, et al. Polymorphic variation in CYP19 and the risk of breast cancer. Carcinogenesis 2001; 22: 347-352.
    • (2001) Carcinogenesis , vol.22 , pp. 347-352
    • Baxter, S.W.1    Choong, D.Y.2    Eccles, D.M.3
  • 31
    • 48749117418 scopus 로고    scopus 로고
    • The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers
    • Huang CS, Kuo SH, Lien HC, et al. The CYP19 TTTA repeat polymorphism is related to the prognosis of premenopausal stage I-II and operable stage III breast cancers. Oncologist 2008; 13: 751-760.
    • (2008) Oncologist , vol.13 , pp. 751-760
    • Huang, C.S.1    Kuo, S.H.2    Lien, H.C.3
  • 32
    • 4043092284 scopus 로고    scopus 로고
    • The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese
    • Hirose K, Matsuo K, Toyama T, et al. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese. Cancer Epidemiol. Biomarkers Prev 2004; 13: 1407-1411.
    • (2004) Cancer Epidemiol. Biomarkers Prev , vol.13 , pp. 1407-1411
    • Hirose, K.1    Matsuo, K.2    Toyama, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.